Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  14,282 نتائج ل ""Diabetes Mellitus""

فلترة النتائج

Subject : hypoglycemic agents
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage

  • Source: Nutrients [Nutrients] 2024 Aug 03; Vol. 16 (15). Date of Electronic Publication: 2024 Aug 03.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.

  • Authors : Saadi MSS; Chester Medical School, Faculty of Health, Medicine and Society, University of Chester, Chester CH1 4BJ, UK.; Das R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Bone Density*/Bone Density*/Bone Density*/drug effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 22; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Polyphenols*/Polyphenols*/Polyphenols*/pharmacology

  • Source: Biomolecules [Biomolecules] 2024 Jul 11; Vol. 14 (7). Date of Electronic Publication: 2024 Jul 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The potential of Myrmecodia pendans in preventing complications of diabetes mellitus as an antidiabetic and antihyperlipidemic agent.

  • Authors : Daulay M; Department of Physiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.; Syahputra M

Subjects: Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/administration & dosage ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/administration & dosage Myrmecodia

  • Source: Open veterinary journal [Open Vet J] 2024 Jul; Vol. 14 (7), pp. 1607-1613. Date of Electronic Publication: 2024 Jul 31.Publisher: Faculty of Veterinary Medicine, University of Tripoli Country of Publication: Libya NLM ID: 101653182 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

  • Authors : Lee JE; Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.; Yu SH

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage ; Metformin*/Metformin*/Metformin*/therapeutic use

  • Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Jul; Vol. 48 (4), pp. 730-739. Date of Electronic Publication: Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Diabetes treatment satisfaction among a multi-ethnic Aotearoa New Zealand population with uncontrolled type 2 diabetes mellitus.

  • Authors : Tweedie-Cullen RY; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; Auckland Diabetes Centre, Auckland District Health Board, Auckland, New Zealand.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/ethnology ; Patient Satisfaction*

  • Source: The New Zealand medical journal [N Z Med J] 2024 Aug 02; Vol. 137 (1600), pp. 66-75. Date of Electronic Publication: 2024 Aug 02.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists.

  • Authors : Lai HW; Taipei Medical University, Taipei, Taiwan. .; See CY

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/mortality ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/diagnosis ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jul 29; Vol. 23 (1), pp. 277. Date of Electronic Publication: 2024 Jul 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.

  • Authors : Andriessen C; Department of General Practice, Amsterdam UMC, Location Vrije Universiteit, Meibergdreef 15, Amsterdam, 1105AZ, the Netherlands.; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Deprescriptions*

  • Source: Trials [Trials] 2024 Jul 25; Vol. 25 (1), pp. 505. Date of Electronic Publication: 2024 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics.

  • Authors : Inokuchi T; Inokuchi Medical Clinic, Fukuoka, Japan.; Department of Auditors, Japan Physicians Association, Tokyo, Japan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2024 Sep; Vol. 15 (9), pp. 1202-1210. Date of Electronic Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus.

  • Authors : Raza H; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan.; Bhutta ME

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/pharmacology

  • Source: Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Aug; Vol. 24 (3), pp. 418-419. Date of Electronic Publication: 2024 Aug 29.Publisher: Sultan Qaboos University Country of Publication: Oman NLM ID: 101519915 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  14,282 نتائج ل ""Diabetes Mellitus""